Fineline Cube

Follow:
14435 Articles
Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
CompanyDeals

Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China

Major Policy Directions in China's Healthcare Arena: A Comprehensive Breakdown
Policy / Regulatory

Major Policy Directions in China’s Healthcare Arena: A Comprehensive Breakdown

RongCan Biotech's mRNA HPV Vaccine Receives FDA Clinical Approval
CompanyDrug

RongCan Biotech’s mRNA HPV Vaccine Receives FDA Clinical Approval

Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
CompanyDeals

Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies

Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
CompanyDeals

Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs

Baheal Pharmaceutical Gains Exclusive Rights to Roche's MabThera in China
CompanyDeals

Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China

Zhejiang Huahai's HB0034 Meets Primary Endpoint in GPP Study
CompanyDrug

Zhejiang Huahai’s HB0034 Meets Primary Endpoint in GPP Study

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
CompanyDeals

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America

Fosun Pharma's 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial
CompanyDrug

Fosun Pharma’s 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
CompanyDeals

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206

Hainan Poly Pharm's US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
CompanyDeals

Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents

Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies
CompanyDeals

Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies